Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 12.89M | $ 28.14M | $ 10.64M | $ 9.42M | $ 13.43M |
Total Assets | $ 252.30M | $ 288.62M | $ 281.73M | $ 301.24M | $ 306.79M |
Total Debt | $ 89.04M | $ 102.31M | $ 108.11M | $ 129.24M | $ 133.50M |
Net Debt | $ 76.15M | $ 74.17M | $ 97.47M | $ 119.83M | $ 120.08M |
Total Liabilities | $ 96.56M | $ 111.42M | $ 118.14M | $ 143.41M | $ 148.42M |
Stockholders Equity | $ 155.74M | $ 177.20M | $ 163.59M | $ 157.83M | $ 158.37M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |